Rentokil Initial plc (LON:RTO – Get Free Report) has been given an average recommendation of “Moderate Buy” by the seven analysts that are presently covering the firm, MarketBeat Ratings reports. One equities research analyst has rated the stock with a sell rating, one has given a hold rating and five have given a buy rating to the company. The average 12 month price objective among brokers that have covered the stock in the last year is GBX 463.
RTO has been the subject of several research reports. Royal Bank Of Canada lowered their price objective on shares of Rentokil Initial from GBX 540 to GBX 480 and set an “outperform” rating for the company in a research report on Thursday. Jefferies Financial Group reiterated a “buy” rating and issued a GBX 550 price target on shares of Rentokil Initial in a report on Thursday, July 9th. Citigroup dropped their price objective on Rentokil Initial from GBX 575 to GBX 550 and set a “buy” rating for the company in a report on Friday. Finally, JPMorgan Chase & Co. reduced their target price on shares of Rentokil Initial from GBX 477 to GBX 431 and set an “overweight” rating on the stock in a research note on Friday.
View Our Latest Stock Report on RTO
Rentokil Initial Price Performance
Rentokil Initial Company Profile
Rentokil Initial plc, together with its subsidiaries, provides route-based services in North America, the United Kingdom, rest of Europe, Asia, the Pacific, and internationally. It offers a range of pest control services for rodents, and flying and crawling insects, as well as other forms of wildlife management for commercial customers. The company provides hygiene services, including the provision and maintenance of products, such as soap and hand sanitizer dispensers, hand dryers, air care and purification, cubicle and surface sanitizers, feminine hygiene units, toilet paper dispensers, and floor protection mats.
Featured Stories
- Five stocks we like better than Rentokil Initial
- Popular’s Earnings Beat Shows Why This Bank Stock Keeps Climbing
- ABB’s Rotork Deal Could Put These Flow Control Stocks Back in Focus
- GE HealthCare Stock Climbs on Vital Diagnostics Demand
- Lost in Space: Why Aerospace Valuations Are Plummeting Right Now
Receive News & Ratings for Rentokil Initial Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Rentokil Initial and related companies with MarketBeat.com's FREE daily email newsletter.
